These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15927799)

  • 1. Tropisetron improves deficits in auditory P50 suppression in schizophrenia.
    Koike K; Hashimoto K; Takai N; Shimizu E; Komatsu N; Watanabe H; Nakazato M; Okamura N; Stevens KE; Freedman R; Iyo M
    Schizophr Res; 2005 Jul; 76(1):67-72. PubMed ID: 15927799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tropisetron improves deficient inhibitory auditory processing in DBA/2 mice: role of alpha 7 nicotinic acetylcholine receptors.
    Hashimoto K; Iyo M; Freedman R; Stevens KE
    Psychopharmacology (Berl); 2005 Nov; 183(1):13-9. PubMed ID: 16136299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia.
    Zhang XY; Liu L; Liu S; Hong X; Chen DC; Xiu MH; Yang FD; Zhang Z; Zhang X; Kosten TA; Kosten TR
    Am J Psychiatry; 2012 Sep; 169(9):974-81. PubMed ID: 22952075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia.
    Olincy A; Harris JG; Johnson LL; Pender V; Kongs S; Allensworth D; Ellis J; Zerbe GO; Leonard S; Stevens KE; Stevens JO; Martin L; Adler LE; Soti F; Kem WR; Freedman R
    Arch Gen Psychiatry; 2006 Jun; 63(6):630-8. PubMed ID: 16754836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia.
    Potter D; Summerfelt A; Gold J; Buchanan RW
    Schizophr Bull; 2006 Oct; 32(4):692-700. PubMed ID: 16469942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of new therapeutic drugs based on the pathophysiology of schizophrenia].
    Hashimoto K
    Seishin Shinkeigaku Zasshi; 2011; 113(4):368-73. PubMed ID: 21702128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinic receptor desensitization and sensory gating deficits in schizophrenia.
    Griffith JM; O'Neill JE; Petty F; Garver D; Young D; Freedman R
    Biol Psychiatry; 1998 Jul; 44(2):98-106. PubMed ID: 9646891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.
    Martin LF; Kem WR; Freedman R
    Psychopharmacology (Berl); 2004 Jun; 174(1):54-64. PubMed ID: 15205879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved p50 auditory gating with ondansetron in medicated schizophrenia patients.
    Adler LE; Cawthra EM; Donovan KA; Harris JG; Nagamoto HT; Olincy A; Waldo MC
    Am J Psychiatry; 2005 Feb; 162(2):386-8. PubMed ID: 15677607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker.
    Hashimoto K
    Curr Pharm Des; 2015; 21(26):3797-806. PubMed ID: 26044974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α7 nicotinic acetylcholine receptor as a potential therapeutic target for schizophrenia.
    Ishikawa M; Hashimoto K
    Curr Pharm Des; 2011; 17(2):121-9. PubMed ID: 21355839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia.
    Moxon KA; Gerhardt GA; Adler LE
    Biol Cybern; 2003 Apr; 88(4):265-75. PubMed ID: 12690485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine reuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evoked potentials.
    Siegel SJ; Maxwell CR; Majumdar S; Trief DF; Lerman C; Gur RE; Kanes SJ; Liang Y
    Neuroscience; 2005; 133(3):729-38. PubMed ID: 15908134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinic modulation of auditory evoked potential electroencephalography in a rodent neurodevelopmental model of schizophrenia.
    Kohlhaas KL; Robb HM; Roderwald VA; Rueter LE
    Biochem Pharmacol; 2015 Oct; 97(4):482-487. PubMed ID: 26032639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining CDP-choline and galantamine: Effects of a selective α7 nicotinic acetylcholine receptor agonist strategy on P50 sensory gating of speech sounds in healthy volunteers.
    Choueiry J; Blais CM; Shah D; Smith D; Fisher D; Illivitsky V; Knott V
    J Psychopharmacol; 2019 Jun; 33(6):688-699. PubMed ID: 30920339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of tropisetron: role of alpha7 nicotinic receptors.
    Hashimoto K; Fujita Y; Ishima T; Hagiwara H; Iyo M
    Eur J Pharmacol; 2006 Dec; 553(1-3):191-5. PubMed ID: 17094961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men.
    Olincy A; Stevens KE
    Biochem Pharmacol; 2007 Oct; 74(8):1192-201. PubMed ID: 17714692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schizophrenia, sensory gating, and nicotinic receptors.
    Adler LE; Olincy A; Waldo M; Harris JG; Griffith J; Stevens K; Flach K; Nagamoto H; Bickford P; Leonard S; Freedman R
    Schizophr Bull; 1998; 24(2):189-202. PubMed ID: 9613620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine improves deficient inhibitory auditory processing in DBA/2 mice, via a nicotinic cholinergic mechanism.
    Simosky JK; Stevens KE; Adler LE; Freedman R
    Psychopharmacology (Berl); 2003 Feb; 165(4):386-96. PubMed ID: 12459928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective alpha7 nicotinic receptor partial agonist.
    Macor JE; Gurley D; Lanthorn T; Loch J; Mack RA; Mullen G; Tran O; Wright N; Gordon JC
    Bioorg Med Chem Lett; 2001 Feb; 11(3):319-21. PubMed ID: 11212100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.